Turning Point Benefit Group’s Cognizant CTSH Stock Holding History

Turning Point Benefit Group’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23	Closed	-$1.91K	–	260
2025 Q4	$1.91K	Sell	23 -5	-18%	-$374	﹤0.01%	455
2025 Q3	$1.86K	Buy	+28	New	+$2.02K	﹤0.01%	312

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Turning Point Benefit Group's CTSH Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 23 shares — an estimated $1.91K sold.

Turning Point Benefit Group first reported a position in CTSH in Q3 2025 and held it in 2 quarters. The position peaked at $1.91K in Q4 2025. 996 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Turning Point Benefit Group reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 23 Cognizant shares in Q1 2026, an estimated $1.91K.
Turning Point Benefit Group first reported a position in Cognizant in Q3 2025 and held it in 2 quarters.
Turning Point Benefit Group's Cognizant position peaked at $1.91K in Q4 2025.
996 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.